Showing results (241-250 of 407) with videos related to

Sort By:
Pageof 41
Stem Cells (Dayton, Ohio)|June 4, 2014
STAT3 signaling is activated preferentially in tumor-initiating cells in claudin-low models of human breast cancerWei Wei, David J Tweardy, Mei Zhang, et al.
Breast Cancer Research and Treatment|November 20, 2009
Nuclear IRS-1 predicts tamoxifen response in patients with early breast cancerIlenia Migliaccio, Meng-Fen Wu, Carolina Gutierrez, et al.
Breast Cancer Research : BCR|September 3, 2011
β1 integrin mediates an alternative survival pathway in breast cancer cells resistant to lapatinibCatherine Huang, Catherine C Park, Susan G Hilsenbeck, et al.
Pediatric Hematology and Oncology|December 13, 2018
Hypothyroidism after craniospinal irradiation with proton or photon therapy in patients with medulloblastomaKevin Bielamowicz, M Fatih Okcu, Rona Sonabend, et al.
Cancer Chemotherapy and Pharmacology|November 30, 2018
A prospective study of a simple algorithm to individually dose high-dose methotrexate for children with leukemia at risk for methotrexate toxicitiesJennifer H Foster, Patrick A Thompson, M Brooke Bernhardt, et al.
Cancer Research|August 17, 2000
A hypersensitive estrogen receptor-alpha mutation in premalignant breast lesionsS A Fuqua, C Wiltschke, Q X Zhang, et al.
Science Translational Medicine|January 21, 2012
Cigarette smoke induction of osteopontin (SPP1) mediates T(H)17 inflammation in human and experimental emphysemaMing Shan, Xiaoyi Yuan, Li-Zhen Song, et al.
The American Journal of Medicine|August 4, 1998
A randomized trial of continuous or intermittent therapy with fluconazole for oropharyngeal candidiasis in HIV-infected patients: clinical outcomes and development of fluconazole resistanceS G Revankar, W R Kirkpatrick, R K McAtee, et al.
Oncogene|October 26, 2002
Inhibition of AP-1 transcription factor causes blockade of multiple signal transduction pathways and inhibits breast cancer growthYongmin Liu, John Ludes-Meyers, Yun Zhang, et al.
Journal of the National Cancer Institute|March 6, 2003
Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancerC Kent Osborne, Valerie Bardou, Torsten A Hopp, et al.
Pageof 41